Jinjian P. Yang

1 Jianshedong Rd
Zhengzhou, 450000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 64 publications

Association between autoimmune diseases and male reproductive health: A mendelian randomization study.

Association between autoimmune diseases and male reproductive health: A mendelian randomization study.

Journal: Science progress

Published: July 16, 2026

Multi-omics analysis suggests ZDHHC18 as a potential risk factor for clear cell renal cell carcinoma linked to myeloid DC morphology.

Multi-omics analysis suggests ZDHHC18 as a potential risk factor for clear cell renal cell carcinoma linked to myeloid DC morphology.

Journal: Discover oncology

Published: August 25, 2025

Docetaxel induced activation of GSDME pathway and pyroptosis enhance immune lethality in prostate cancer cells.

Docetaxel induced activation of GSDME pathway and pyroptosis enhance immune lethality in prostate cancer cells.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 21, 2025

Targeted inhibition of the CREB1-CtIP axis enhances the efficacy of abiraterone combined with radiotherapy in prostate cancer.

Targeted inhibition of the CREB1-CtIP axis enhances the efficacy of abiraterone combined with radiotherapy in prostate cancer.

Journal: Cell death & disease

Published: July 14, 2025

The Oncopromoting Gene RBM6 Inhibits Prostate Tumour Cell Migration During Epithelial-to-Mesenchymal Transition.

The Oncopromoting Gene RBM6 Inhibits Prostate Tumour Cell Migration During Epithelial-to-Mesenchymal Transition.

Journal: Journal of cellular and molecular medicine

Published: November 29, 2024

Secrets revealed by the skin: initial success of tislelizumab and targeted therapy in advanced renal cell carcinoma-a case report and literature review.

Secrets revealed by the skin: initial success of tislelizumab and targeted therapy in advanced renal cell carcinoma-a case report and literature review.

Journal: Translational andrology and urology

Published: August 15, 2024

Phosphatase LHPP confers prostate cancer ferroptosis activation by modulating the AKT-SKP2-ACSL4 pathway.

Phosphatase LHPP confers prostate cancer ferroptosis activation by modulating the AKT-SKP2-ACSL4 pathway.

Journal: Cell death & disease

Published: April 16, 2024

Enzalutamide inhibits PEX10 function and sensitizes prostate cancer cells to ROS activators.

Enzalutamide inhibits PEX10 function and sensitizes prostate cancer cells to ROS activators.

Journal: Cell death & disease

Published: March 01, 2024

TDO2 promotes bladder cancer progression via AhR-mediated SPARC/FILIP1L signaling.

TDO2 promotes bladder cancer progression via AhR-mediated SPARC/FILIP1L signaling.

Journal: Biochemical pharmacology

Published: December 14, 2023

LINC00645 inhibits renal cell carcinoma progression by interacting with HNRNPA2B1 to regulate the ROCK1 mRNA stability.

LINC00645 inhibits renal cell carcinoma progression by interacting with HNRNPA2B1 to regulate the ROCK1 mRNA stability.

Journal: Gene

Published: November 16, 2023

Bibliometric and Visualization Analysis of Stem Cell Therapy for Erectile Dysfunction.

Bibliometric and Visualization Analysis of Stem Cell Therapy for Erectile Dysfunction.

Journal: Drug design, development and therapy

Published: November 06, 2023

8-Br-cGMP activates HSPB6 and increases the antineoplastic activity of quinidine in prostate cancer.

8-Br-cGMP activates HSPB6 and increases the antineoplastic activity of quinidine in prostate cancer.

Journal: Cell death discovery

Published: September 23, 2023

Showing 1-12 of 64

Last Updated: 09/26/2026